Status:
WITHDRAWN
BPOI (Berlin Pediatric Oxygenation Index) - A New Predictor for Imminent Failure of HFNC in Children Avoiding Delayed NIV or Intubation
Lead Sponsor:
Charite University, Berlin, Germany
Conditions:
Respiratory Failure (Pediatric Patients)
Eligibility:
All Genders
28-17 years
Brief Summary
The investigators developed an index that integrates different flow-settings in High-flow nasal cannula (HFNC) therapy with non-invasively measured clinical parameters of oxygenation in pediatric pati...
Detailed Description
High-flow nasal cannula therapy is a broadly used instrument of respiratory support in pediatric and adult patients with respiratory failure. For adult patients with pneumonia and respiratory failure...
Eligibility Criteria
Inclusion
- Patients with respiratory failure and indication für High-flow nasal cannula therapy
- Patients aged between 4 1/7 weeks and 18 years
- Patients who were treated between 01/01/2017 and 28/02/2021 in the Department of Pediatric Pulmonology, Immunology and Intensive Care Medicine at Campus Virchow- Klinikum, Charité - Universitätsmedizin Berlin
Exclusion
- Patients aged between 1 and 27 days (neonatal period)
- Patients with congenital cyanotic heart defects
- Patients after or in the course of haematopoetic stem cell transplantation
- Patients with ambulatory respiratory support
Key Trial Info
Start Date :
June 21 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04895332
Start Date
June 21 2021
End Date
December 31 2021
Last Update
January 18 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.